NCT03672123 is a clinical trial in Pulmonary Embolism, sponsored by Medical University of Warsaw.

Who is sponsoring NCT03672123?

NCT03672123 is sponsored by Medical University of Warsaw.

What condition does NCT03672123 study?

NCT03672123 studies Pulmonary Embolism.

Is NCT03672123 still recruiting?

NCT03672123 is currently completed. Last updated 31 October 2023.

Last reviewed 2023-10-31 · How we verify

NCT03672123

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

GDF-15 Levels in Risk Stratification in Acute Pulmonary Embolism

Completed Last updated 31 October 2023

What this trial tests

trial in Pulmonary Embolism in 270 participants. Completed in 30 June 2023.

Timeline

17 September 2018

Primary endpoint
30 June 2023

30 June 2023

Quick facts

Lead sponsor	Medical University of Warsaw
Status	Completed
Study type	OBSERVATIONAL
Enrollment	270
Start date	17 September 2018
Primary completion	30 June 2023
Estimated completion	30 June 2023
Sites	1 location across Poland

Conditions studied

Pulmonary Embolism — all drugs for Pulmonary Embolism →

Sponsor

Medical University of Warsaw

Who can join

18 and older, any sex, with Pulmonary Embolism. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Prospective observational study evaluating serum GDF-15 levels in patients with acute pulmonary embolism.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Pulmonary Embolism

Currently open trials in the same condition.

NCT07381712 — High-Flow Nasal Cannula Versus Non-Invasive Ventilation for Acute Respiratory Failure in Pulmonary Embolism. · NA · active not recruiting
NCT04211181 — CHIPs-VTE Study in Hospitalized Patients to Prevent Hospital-Acquired Venous Thromboembolism · NA · recruiting
NCT07003646 — Reperfusion Treatment in Acute Pulmonary Embolism · recruiting
NCT06600542 — Inari VISION Registry · recruiting
NCT06622876 — Incidental Discovery of Pulmonary Emboli Via CT Scan: Impact of Detections on Patient Care and Resulting Complications · recruiting

Other Medical University of Warsaw trials

Trials by the same sponsor.

NCT07515768 — TAVI Without On-Site Cardiac Surgery in Poland: A Randomized Multicenter Trial Protocol · NA · not yet recruiting
NCT07511907 — Routine Intraoperative White Test for Bile Leak Detection in Liver Resection · NA · not yet recruiting
NCT07498660 — PRP Injection Into the Sacroiliac Joint After Ipsilateral THA: Effects on Early Recovery and Function (SIJ-THA Randomize · NA · not yet recruiting
NCT07398898 — Use of Augmented Reality Glasses and Noise-Cancelling Headphones to Reduce Dental Anxiety in Adult Patients · NA · recruiting
NCT07237204 — 15 vs 45 Minute Pringle Maneuver in Liver Cancer Resection: Randomized Noninferiority Trial · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03672123 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Medical University of Warsaw
Last refreshed: 31 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03672123.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing